Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Assessment of disease status and surveillance after treatment in patients with primary brain tumors

Patrick Y Wen, MD
Section Editor
Jay S Loeffler, MD
Deputy Editor
April F Eichler, MD, MPH


For patients with primary brain tumors, appropriate management requires a determination of whether a patient is responding to therapy or is progressing. The integration of improvements in neuroimaging (MRI, CT, newer techniques) provides valuable information, but significant issues remain.

Developments in response criteria for both high-grade and low-grade gliomas are reviewed here. The management of these tumors is discussed separately:

(See "Clinical manifestations and initial surgical approach to patients with high-grade gliomas".)

(See "Initial postoperative therapy for glioblastoma and anaplastic astrocytoma".)

(See "Adjuvant radiation therapy for high-grade gliomas".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2017. | This topic last updated: Nov 30, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.